StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Evofem Biosciences's price to book ratio was 11.9× on Oct 29, 2021, against 145.4× a year earlier. Over the last 5 years it ranged from 0.3× to 265.5×, with a median of 3.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 202111.9×+7.0
2020Dec 31, 20204.9×−7.1
2019Dec 31, 201912.0×−4.1
2018Oct 31, 201816.1×+10.5
2017Dec 29, 20175.6×+4.4
2016Dec 30, 20161.1×+0.5
2015Dec 31, 20150.6×–

More Evofem Biosciences figures

See a number that looks wrong?